Showing 1351-1360 of 1395 results for "".
- Bausch Health CEO: Big Pharma Will Survive US Drug Regulationshttps://modernod.com/news/bausch-health-ceo-big-pharma-will-survive-us-drug-regulations/2476798/Bausch Health Chariman and CEO Joseph C. Papa told CNBC on Wednesday that he isn’t too concerned about the future of the pharmaceutical industry despite pledges from Congress to lower
- Wize Pharma Enters Joint Venture With Cannabics Pharmaceuticals to Develop Cannabinoid Ophthalmic Treatmentshttps://modernod.com/news/wize-pharma-enters-joint-venture-with-cannabics-pharmaceuticals-to-develop-cannabinoid-ophthalmic-treatments/2476713/Israel-based Wize Pharma and Cannabics Pharmaceuticals have together created and adopted a business plan for a joint venture focused on the research and development of cannabinoid formulations to treat ophthalmic conditions. Creation and approval of a business plan for the joint venture was a con
- Research Shows Gene Therapy May Restore Visual Function for People With Night Blindnesshttps://modernod.com/news/research-shows-gene-therapy-may-restore-visual-function-for-people-with-night-blindness/2476663/By isolating where a key protein required for low light vision is expressed, scientists have shown that gene therapy may restore visual function for people with a form of congenital stationary night blindness. In mice models with genetic mutations similar to humans with night blindness, sc
- LKC Technologies Launches New UTAS Systems at ARVOhttps://modernod.com/news/lkc-technologies-launches-new-utas-systems-at-arvo/2476520/LKC Technologies has announced the launch of new UTAS systems at the ARVO meeting in Vancouver (booth #1003). The UTAS SunBurst is a small, lightweight and easy to use system capable of conducting full ISCEV-complaint electroretinograms (ERGs), visual evoked potential (VEPs) tests, and ele
- Fraunhofer IAP Developing Contact lenses With Medicine and Sugarhttps://modernod.com/news/fraunhofer-iap-developing-contact-lenses-with-medicine-and-sugar/2476476/Researchers at the Fraunhofer Institute for Applied Polymer Research IAP are working with Israeli and German partners to develop long-wearing contact lenses that can release medicine. The active ingredient is encapsulated in liposomes and bound to the inside of the contact lenses. This enables it
- Proxy Advisory Firms Back Allergan in Battle with Dissident Shareholder Appaloosahttps://modernod.com/news/proxy-advisory-firms-back-allergan-in-battle-with-dissident-shareholder-appaloosa/2476472/Allergan said Monday that proxy advisory firms Institutional Shareholder Services (ISS) and Glass Lewis have recommended that shareholders vote for all of the board’s proposals at its annual meeting on May 1, and against hedge fund Appaloosa’s proposal calling for the immediate separa
- Avedro’s Corneal Cross-Linking Procedure Now Covered by 65 Coverage Policieshttps://modernod.com/news/avedros-corneal-cross-linking-procedure-now-covered-by-65-coverage-policies/2476444/Avedro announced that four new providers—Providence Health Plan in the Pacific Northwest, Health New England, HealthPartners Minnesota, and Public Employees Health Plan (PEHP) in Utah—have issued positive coverage pol
- Study: Vision Loss Has Significant Impact on Use of Hospital Resources and Costs for Older Patientshttps://modernod.com/news/study-vision-loss-has-significant-impact-on-use-of-hospital-resources-and-costs-for-older-patients/2476440/A national study has found that older patients with vision loss who are hospitalized for common disorders are often not identified as requiring special attention, which can affect outcomes, resource use, and costs. The study is published in the April 4 issue o
- Ocutrx Vision Technologies Receives Second Patent for Augmented Reality Glasses Eye Tracking Technologyhttps://modernod.com/news/ocutrx-vision-technologies-receives-second-patent-for-augmented-reality-glasses-eye-tracking-technology/2476434/Ocutrx Vision Technologies, a manufacturer of augmented reality (AR) glasses, announced the issuance of the company’s second US patent, which will protect the company’s unique eye tracking technology for patients with macular degeneration and other low vision conditions. The patent applies to bot
- VisionCare Announces Regulatory Approval of the CentraSight Treatment Program in Australiahttps://modernod.com/news/visioncare-announces-regulatory-approval-of-the-centrasight-treatment-program-in-australia/2476395/VisionCare announced that the Australian Department of Health Therapeutic Goods Administration has issued a Therapeutic Goods Certificate to the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), approving it for the improvement of visual acuity in patients who are 55 years and older with b